About Caring4Cancer

 
Caring4Cancer's mission is to provide a complete source of knowledge and support for people with cancer, empowering them with the expertise, strength and hope they need to live their lives to the fullest. Caring4Cancer combines a virtual encyclopedia of cancer information with a collection of powerful tools that help patients take an active role in managing their disease. Our world-renowned Oncology Advisory Board reviews our content for accuracy and timeliness.

At Caring4Cancer, you can:

  • Shape the content to match your specific cancer type, diagnosis, and phase of treatment or recovery
  • Interact with other patients and experts through our message boards
  • Keep track of your symptoms, treatments, and appointments with a secure Patient Health Record and Symptom Tracker
  • View online videos right in your doctor’s office or in the comfort of your own home
  • Sign up for e-newsletters tailored to your interests and needs.
  • Create your own personal web page where you can keep a personal journal, exchange messages of encouragement, share pictures, and more.

Hundreds of oncology practices are now prescribing Caring4Cancer’s educational and interactive tools to their patients, just as they prescribe medication or therapy.However, the content at Caring4Cancer is not intended to be a substitute for professional medical advice, diagnosis, or treatment. For information on how to contact us, please click here.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health